Cargando…

Hyponatremia as a prognostic factor in non-small cell lung cancer: a systematic review and meta-analysis

BACKGROUND: Hyponatremia is a common electrolyte disorder in cancer patients and has been evaluated as a negative prognostic factor in several cancer types, especially in small cell lung cancer (SCLC). However, the prognostic value of hyponatremia is less studied in non-small cell lung cancer (NSCLC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sandfeld-Paulsen, Birgitte, Aggerholm-Pedersen, Ninna, Winther-Larsen, Anne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947424/ https://www.ncbi.nlm.nih.gov/pubmed/33718011 http://dx.doi.org/10.21037/tlcr-20-877

Ejemplares similares

Inflammation scores as prognostic biomarkers in small cell lung cancer: a systematic review and meta-analysis
por: Winther-Larsen, Anne, et al.
Publicado: (2021)

Inflammation-scores as prognostic markers of overall survival in lung cancer: a register-based study of 6,210 Danish lung cancer patients
por: Winther-Larsen, Anne, et al.
Publicado: (2022)

Pretreatment Albumin-to-Alkaline Phosphatase Ratio Is a Prognostic Marker in Lung Cancer Patients: A Registry-Based Study of 7077 Lung Cancer Patients
por: Sandfeld-Paulsen, Birgitte, et al.
Publicado: (2021)

Targeted Treatment of Soft-Tissue Sarcoma
por: Riskjell, Anne Iren, et al.
Publicado: (2023)

A Cohort Study of Free Light Chain Ratio in Combination with Serum Protein Electrophoresis as a First-Line Test in General Practice
por: Sandfeld-Paulsen, Birgitte, et al.
Publicado: (2022)

Role of high‑sensitivity C‑reactive protein in patients with sarcoma
por: Aggerholm-Pedersen, Ninna, et al.
Publicado: (2023)

Inclusion of Metabolic Tumor Volume in Prognostic Models of Bone and Soft Tissue Sarcoma Increases the Prognostic Value
por: Pedersen, Mette Abildgaard, et al.
Publicado: (2023)

Macrophage Biomarkers sCD163 and sSIRPα in Serum Predict Mortality in Sarcoma Patients
por: Aggerholm-Pedersen, Ninna, et al.
Publicado: (2023)

Exosomal proteins as prognostic biomarkers in non‐small cell lung cancer
por: Sandfeld-Paulsen, B., et al.
Publicado: (2016)

The Prognostic Value of Plasma Programmed Death Protein-1 (PD-1) and Programmed Death-Ligand 1 (PD-L1) in Patients with Gastrointestinal Stromal Tumor
por: Brinch, Charlotte Margareta, et al.
Publicado: (2022)

Gene Expression of the EGF System—a Prognostic Model in Non–Small Cell Lung Cancer Patients Without Activating EGFR Mutations()
por: Sandfeld-Paulsen, Birgitte, et al.
Publicado: (2016)

Neurofilament Light Chain as A Biomarker for Brain Metastases
por: Winther-Larsen, Anne, et al.
Publicado: (2020)

A Validated Prognostic Biomarker Score for Adult Patients with Nonmetastatic Soft Tissue Sarcomas of the Trunk and Extremities
por: Maretty-Kongstad, Katja, et al.
Publicado: (2017)

The Prognostic Value of Serum Biomarkers in Localized Bone Sarcoma()
por: Aggerholm-Pedersen, Ninna, et al.
Publicado: (2016)

Prevalence and Prognostic Significance of Hyponatremia in Patients With Lung Cancer: Systematic Review and Meta-Analysis
por: Bartalis, Eszter, et al.
Publicado: (2021)

Rhabdomyosarcoma in Adults: A Retrospective Analysis of Case Records Diagnosed between 1979 and 2018 in Western Denmark
por: Mäkinen, Vivi-Nelli, et al.
Publicado: (2021)

Hyponatremia of non-small cell lung cancer: Indian experience
por: Bose, Chinmoy K., et al.
Publicado: (2011)

Prognostic factors for local recurrence and mortality in adult soft tissue sarcoma of the extremities and trunk wall: A cohort study of 922 consecutive patients
por: Maretty-Nielsen, Katja, et al.
Publicado: (2014)

Pazopanib in the Treatment of Bone Sarcomas: Clinical Experience()
por: Aggerholm-Pedersen, Ninna, et al.
Publicado: (2019)

Hyponatremia normalization as an independent prognostic factor in patients with advanced non-small cell lung cancer treated with first-line therapy
por: Berardi, Rossana, et al.
Publicado: (2016)

cGAS-STING pathway expression as a prognostic tool in NSCLC
por: Raaby Gammelgaard, Kristine, et al.
Publicado: (2021)

Comorbidity in Adult Bone Sarcoma Patients: A Population-Based Cohort Study
por: Aggerholm-Pedersen, Ninna, et al.
Publicado: (2014)

Relative mortality in soft tissue sarcoma patients: a Danish population-based cohort study
por: Maretty-Nielsen, Katja, et al.
Publicado: (2014)

Population-based Aarhus Sarcoma Registry: validity, completeness of registration, and incidence of bone and soft tissue sarcomas in western Denmark
por: Maretty-Nielsen, Katja, et al.
Publicado: (2013)

Severe hyponatremia as presenting symptom of small cell lung carcinoma
por: Stevchevska, Aleksandra, et al.
Publicado: (2023)

Serum Natrium Determines Outcome of Treatment of Advanced GIST with Imatinib: A Retrospective Study of 80 Patients from a Single Institution
por: Aggerholm-Pedersen, Ninna, et al.
Publicado: (2011)

Dasatinib and Doxorubicin Treatment of Sarcoma Initiating Cells: A Possible New Treatment Strategy
por: Aggerholm-Pedersen, Ninna, et al.
Publicado: (2016)

A prognostic profile of hypoxia-induced genes for localised high-grade soft tissue sarcoma
por: Aggerholm-Pedersen, Ninna, et al.
Publicado: (2016)

Hyponatremia—Long-Term Prognostic Factor for Nonfatal Pulmonary Embolism
por: Ouatu, Anca, et al.
Publicado: (2021)

Inflammatory Cytokines and ctDNA Are Biomarkers for Progression in Advanced-Stage Melanoma Patients Receiving Checkpoint Inhibitors
por: Pedersen, Jesper Geert, et al.
Publicado: (2020)

The Prognostic Value of Hyponatremia for Predicting Poor Outcome in Patients With COVID-19: A Systematic Review and Meta-Analysis
por: Akbar, Mohammad Rizki, et al.
Publicado: (2021)

The Importance of Reference Gene Analysis of Formalin-Fixed, Paraffin-Embedded Samples from Sarcoma Patients — An Often Underestimated Problem()()
por: Aggerholm-Pedersen, Ninna, et al.
Publicado: (2014)

Exosomal proteins as potential diagnostic markers in advanced non-small cell lung carcinoma
por: Jakobsen, Kristine R., et al.
Publicado: (2015)

Hyponatremia as a prognostic and predictive factor in metastatic renal cell carcinoma
por: Jeppesen, A N, et al.
Publicado: (2010)

Short- and long-term prognostic value of hyponatremia in patients with acute coronary syndrome: A systematic review and meta-analysis
por: Ma, Qiang-Qiang, et al.
Publicado: (2018)

Prognostic Value of Glasgow Prognostic Score in Non-small Cell Lung Cancer: A Systematic Review and Meta-Analysis
por: Zhang, Chuan-Long, et al.
Publicado: (2022)

CDK7 is a prognostic biomarker for non-small cell lung cancer
por: Kuempers, Christiane, et al.
Publicado: (2022)

Genomic Profiling of Circulating Tumor DNA Predicts Outcome and Demonstrates Tumor Evolution in ALK-Positive Non-Small Cell Lung Cancer Patients
por: Madsen, Anne Tranberg, et al.
Publicado: (2020)

Correlation between circulating mutant DNA and metabolic tumour burden in advanced non-small cell lung cancer patients
por: Winther-Larsen, Anne, et al.
Publicado: (2017)

Coexistent Non–Small Cell Carcinoma and Small Cell Carcinoma in a Patient Presenting with Hyponatremia
por: Ross, Mitchell D., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_cloeg1k561kcgaf1b18nubn9ec